Company Description
T2 Biosystems (OTC Link: TTOO) is a publicly traded diagnostics & research company in the Surgical & Medical Instruments & Apparatus sector. The company has a market capitalization of $2.4M, ranking #6,915 among all listed U.S. companies by market cap.
TTOO stock has declined 98.2% over the past year. Shares last traded at $0.0022.
On a trailing twelve-month basis, T2 Biosystems reported revenue of $7.2M with net income of -$50.1M and diluted earnings per share of $-19.19. The company operates at a net profit margin of -696.2%.
This page provides a comprehensive overview of TTOO stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
T2 Biosystems (TTOO) stock last traded at $0.0022, up 340.00% from the previous close. Over the past 12 months, the stock has lost 98.2%. At a market capitalization of $2.4M, TTOO is classified as a micro-cap stock with approximately 28.0M shares outstanding.
Latest News
T2 Biosystems has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, conferences, AI, fda approval. View all TTOO news →
SEC Filings
T2 Biosystems has filed 1 recent SEC filing, including 1 Form 25-NSE. The most recent filing was submitted on July 10, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TTOO SEC filings →
Financial Highlights
T2 Biosystems generated $7.2M in revenue over the trailing twelve months, operating income reached -$49.7M (-690.4% operating margin), and net income was -$50.1M, reflecting a -696.2% net profit margin. Diluted earnings per share stood at $-19.19. The company generated -$48.1M in operating cash flow. With a current ratio of 0.45, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in T2 Biosystems (TTOO) currently stands at 4.9 thousand shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 52.3%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for T2 Biosystems (TTOO) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
TTOO Company Profile & Sector Positioning
T2 Biosystems (TTOO) operates in the Diagnostics & Research industry within the broader Surgical & Medical Instruments & Apparatus sector and is listed on the OTC Link.
Investors comparing TTOO often look at related companies in the same sector, including Rushnet Inc (RSHN), Identa Ltd Rvice (IDTA), Interpace Biosciences Inc (IDXG), Invitro Internat (IVRO), and Angle Plc Surrey (ANPCF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TTOO's relative position within its industry.